SEC Filing Summary: Marex Group Ltd (Form 13F)
Business Context and Reporting Period
Company: Marex Group Ltd
Filing Type: Form 13F Information Table (Statement of Beneficial Ownership)
Reporting Period: The filing metadata indicates a date of June 30, 2026. However, the content reflects a standard quarterly portfolio disclosure of equity securities held by the investment manager. The filing lists holdings across multiple managers (indicated by "DFND 1", "DFND 2", and "DFND 3" in the voting authority column).
Key Financial Metrics and Portfolio Composition
As a Form 13F filing, this document does not report Marex Group's internal revenue, profit, or cash flow. Instead, it details the value and quantity of securities held by the firm's investment accounts. Key portfolio characteristics include:
- Asset Class: Predominantly U.S. and international common stocks, with significant exposure to Exchange-Traded Funds (ETFs) and derivatives (Put/Call options).
- Top Holdings by Value (Selected):
- Microsoft Corp: Multiple positions totaling over $820 million in value (approx. 2.2 million shares).
- Alphabet Inc (Class A & C): Significant aggregate exposure exceeding $340 million.
- Amazon.com Inc: Holdings valued over $120 million.
- Strategy Inc (MicroStrategy): Substantial positions including calls and puts, with total value exceeding $170 million.
- NVIDIA Corp: Holdings valued over $20 million in the primary listing, with additional significant positions in other manager accounts.
- Derivatives Usage: The portfolio utilizes Put and Call options extensively for hedging and leverage, particularly on large-cap tech stocks (e.g., Microsoft, Alphabet, Amazon, Tesla) and crypto-related equities (e.g., Coinbase, Strategy Inc).
Material Changes and Sector Exposure
The filing reveals a concentrated strategy with heavy weighting in specific thematic sectors:
- Technology & Semiconductors: Heavy concentration in AI and chip manufacturers including NVIDIA, Broadcom, AMD, and Applied Materials.
- Cryptocurrency & Blockchain: Significant exposure to crypto-mining and proxy stocks such as MARA Holdings, Riot Platforms, Coinbase Global, and Strategy Inc (MicroStrategy). The portfolio also holds Bitcoin and Ethereum ETFs (e.g., IBIT, ETHE).
- Healthcare & Biotech: Notable positions in Eli Lilly, UnitedHealth Group, and various biotech firms (e.g., Moderna, Intuitive Surgical).
- Energy & Materials: Exposure to uranium (Cameco, Uranium Energy), oil services, and mining companies.
Guidance, Risks, and Contingencies
Management Commentary: Not applicable. Form 13F is a regulatory disclosure of holdings and does not contain forward-looking guidance or management commentary.
Risks and Contingencies:
- Concentration Risk: The portfolio shows high concentration in volatile sectors (Technology, Crypto, Biotech).
- Derivative Risk: The extensive use of Put and Call options introduces leverage and timing risks.
- Liquidity: While most holdings are large-cap liquid stocks, there are positions in smaller-cap and speculative stocks (e.g., SoundHound AI, Quantum Computing) which may have lower liquidity.
Investor Verification Checklist
- Verify the specific reporting period end date against the filing date to ensure the data reflects the most recent quarter.
- Confirm the total aggregate value of the portfolio by summing the "Value" column across all managers (DFND 1, 2, and 3) to assess total Assets Under Management (AUM) disclosed.
- Review the "Put/Call" column to understand the net directional bias (bullish vs. bearish) on key holdings like Microsoft and Alphabet.
- Check for any "Shared" voting authority to identify co-investment structures or third-party fund managers.
- Validate the CUSIP numbers for any unusual or newly listed securities (e.g., SPACs or recent IPOs) to ensure accurate identification.